Bodhi Tree Biotechnology (BDTB) Cash & Equivalents (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported Cash & Equivalents of $47366.0 for Q4 2025, down 75.62% year-over-year from $194293.0 in Q4 2024, and down 56.71% on a QoQ basis from $109404.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) has 2 years of Cash & Equivalents data on file, last reported at $47366.0 in Q4 2025.
- Quarterly Cash & Equivalents fell 75.62% year-over-year to $47366.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $47366.0 (down 75.62% YoY) and the FY2025 annual result came in at $109404.0, down 57.85% from the prior year.
- Cash & Equivalents eased to $47366.0 in Q4 2025 per BDTB's latest filing, from $109404.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $259570.0 in Q3 2024 and bottomed at $47366.0 in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,366.00 |
| Sep 30, 2025 | 109,404.00 |
| Jun 30, 2025 | 119,516.00 |
| Mar 31, 2025 | 144,165.00 |
| Dec 31, 2024 | 194,293.00 |
| Sep 30, 2024 | 259,570.00 |